Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 33Lung Neoplasms 18Breast Neoplasms 11Ovarian Neoplasms 10Uterine Cervical Neoplasms 6Carcinoma, Ovarian Epithelial 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Fallopian Tube Neoplasms 5Adenocarcinoma of Lung 5Neoplasms 4Neoplasm Metastasis 4Central Nervous System Neoplasms 4Esophageal Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Retinoblastoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Inflammatory Breast Neoplasms 2Gliosarcoma 2Glioblastoma 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thoracic Neoplasms 1Salivary Gland Neoplasms 1

Interventions

veliparib 1bavituximab 1avatrombopag 1Sorafenib 1Radiotherapy 1Radiosurgery 1Paclitaxel 1Immunotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Liver Diseases × Carboplatin × Clear all
NCT01419548 2017-07-02

ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn

Liver Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡